Affiliation:
1. 1 Faculty of Medicine , University “Ovidius” of Constanta
2. 2 Clinical Emergency County Hospital of Constanta
Abstract
Abstract
Objective: Preterm neonates represent a category of neonates at high risk for anemia. Due to particular pathologic processes and clinical presentation in preterm neonates, this type of anemia is described as a separate entity named anemia of prematurity (AOP). The population represented by very low birthweight (VLBW) neonates is at the highest risk of developing anemia of prematurity. Reduced tissue oxygenation due to anemia can have short-term consequences (growth restriction, apnea episodes) or long-term consequences such as delayed neurological development, rapid detection, and management of AOP is needed to avoid its complications.
Material and methods: We describe the particularities of this condition and the interventions for its prevention or correction in a group of premature infants born at less than 32 weeks of gestation discharged home during 2021.
Results: We assessed the presence of anemia and the need for erythrocyte transfusion in 32 VLBW neonates, separated into two groups based on the gestational age: 24-29 gestational weeks (GW) and 30-31 GW. The number of neonates receiving a transfusion and the number of transfusion events was higher in the former, more immature group. We also identified more significant phlebotomy losses in the first group, contributing to a higher proportion of AOP cases needing erythrocyte transfusion.
Conclusions: Although our protocols for transfusion at this moment recommend lower hemoglobin thresholds, we tend to transfuse above those levels based mainly on clinical signs and symptoms. We need better prevention strategies for AOP, both by using cord blood and more strict monitoring of phlebotomy losses.
Subject
General Biochemistry, Genetics and Molecular Biology
Reference12 articles.
1. Matthews DC, Glader B. Erythrocyte disorders in infancy. In: Gleason C, Devaskar S, Avery M, editors. Avery’s diseases of the newborn: 9th ed. Saunders, an imprint of Elsevier Inc.; 2012. p. 952-62.
2. El-Lahony DM, Saleh NY, Habib MS, Shehata MA, El-Hawy MA. The role of recombinant Human erythropoietin in neonatal anemia. Hematol Oncol Stem Cell Ther. 2020 Sep;13(3):147-51.
3. Garcia-Prats J. Anemia of prematurity. Abrams S, Mahoney D, Kim M, editors: UpToDate Inc.; 2020.
4. Gomella T, Cunningham D, Eyal F, Zenk K. Neonatology: Management, Procedures, On-Call Problems, Diseases and Drugs: 5th Ed McGraw Hill 2009.
5. Strauss RG. Anaemia of prematurity: pathophysiology and treatment. Blood Rev. 2010 Nov;24(6):221-5.